EFFECT OF PLATELET-ACTIVATING FACTOR AND ITS SPECIFIC RECEPTOR ANTAGONIST ON GLOMERULAR-PERMEABILITY TO PROTEINS IN ISOLATED PERFUSED RAT-KIDNEY

被引：0
|
作者：
PERICO, N
DELAINI, F
TAGLIAFERRI, M
ABBATE, M
CUCCHI, M
BERTANI, T
REMUZZI, G
机构：
来源：
LABORATORY INVESTIGATION | 1988年 / 58卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：163 / 171
页数：9
相关论文
共 50 条
  • [41] [H-3]52770-RP, A PLATELET-ACTIVATING FACTOR RECEPTOR ANTAGONIST, AND TRITIATED PLATELET-ACTIVATING FACTOR LABEL A COMMON SPECIFIC BINDING-SITE IN HUMAN POLYMORPHONUCLEAR LEUKOCYTES
    MARQUIS, O
    ROBAUT, C
    CAVERO, I
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1988, 244 (02): : 709 - 715
  • [42] ANGIOTENSIN-II (AII) INCREASES ALBUMIN GLOMERULAR-PERMEABILITY IN ISOLATED-PERFUSED RAT-KIDNEY (IPRK) BY A MECHANISM WHICH IS INDEPENDENT FROM ENDOTHELIN-1 (ET-1)
    LAPINSKI, R
    BENIGNI, A
    PERICO, N
    REMUZZI, G
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 662 - 662
  • [43] An oral platelet-activating factor antagonist, Ro-24-4736, protects the rat kidney from ischemic injury
    Kelly, KJ
    TolkoffRubin, NE
    Rubin, RH
    Williams, WW
    Meehan, SM
    Meschter, CL
    Christenson, JG
    Bonventre, JV
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1996, 271 (05) : F1061 - F1067
  • [44] THE EFFECT OF PLATELET ACTIVATING FACTOR (PAF)-RECEPTOR ANTAGONIST ON PROTEINURIA AND GLOMERULAR EICOSANOID SYNTHESIS IN RAT IMMUNE-COMPLEX GLOMERULONEPHRITIS (ICGN)
    SAUTER, D
    ISKANDAR, S
    RAHMAN, M
    KIDNEY INTERNATIONAL, 1989, 35 (01) : 320 - 320
  • [45] PLATELET-ACTIVATING-FACTOR (PAF) MEDIATES ANTIBODY AND COMPLEMENT INDUCED GLOMERULAR MONOCYTE-CHEMOATTRACTANT PROTEIN-1 (MCP-1) EXPRESSION IN THE ISOLATED-PERFUSED RAT-KIDNEY
    JOCKS, T
    FREUDENBERG, J
    ZAHNER, G
    HELMCHEN, U
    STAHL, RAK
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 756 - 756
  • [46] BLEOMYCIN-INDUCED LUNG INJURY IN THE RAT - EFFECTS OF THE PLATELET-ACTIVATING FACTOR (PAF) RECEPTOR ANTAGONIST BN 52021 AND PLATELET DEPLETION
    EVANS, TW
    MCANULTY, RJ
    ROGERS, DF
    CHUNG, KF
    BARNES, PJ
    LAURENT, GJ
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1990, 85 : 65 - 69
  • [47] Effect of the platelet-activating factor antagonist BN-52021 on liver preservation (4°):: Experimental study in isolated reperfused rat liver model
    Castellvi, J
    Borobia, FG
    Figueras, J
    Fradera, R
    Herrero, I
    Torras, J
    Busquets, J
    Fabregat, J
    Jorba, R
    Jaurrieta, E
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (01) : 50 - 52
  • [48] In vitro inhibitory effect of rubraxanthone isolated from Garcinia parvifolia on platelet-activating factor receptor binding
    Jantan, I
    Pisar, MM
    Idris, MS
    Taher, M
    Ali, RM
    PLANTA MEDICA, 2002, 68 (12) : 1133 - 1134
  • [49] Inhibitory effect of pranlukast, a cysteinyl leukotriene receptor-antagonist, on eosinophil activation induced by platelet-activating factor
    Suzuki, M
    Kato, M
    Kimura, H
    Tachibana, A
    Fujiu, T
    Arakawa, H
    Mochizuki, H
    Tokuyama, K
    Morikawa, A
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (01) : S225 - S225
  • [50] Effect of a platelet-activating factor (PAF) receptor antagonist on hyperacute xenograft rejection;: evaluation in a pig kidney-human blood xenoperfusion model
    Cruzado, JM
    Torras, J
    Riera, M
    Lloberas, N
    Herrero, I
    Condom, E
    Martorell, J
    Alsina, J
    Grinyó, JM
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1998, 113 (01): : 136 - 144
12345